Sources:
- January 25, 2021. “Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates.” Merck.
https://www.merck.com/news/merck-discontinues-development-of-sars-cov-2-covid-19-vaccine-candidates-continues-development-of-two-investigational-therapeutic-candidates/.
Business. - January 25, 2021. “Merck Ends COVID-19 Vaccine Program, Cites Inferior Immune Responses.” Reuters. Fox Business.
https://www.foxbusiness.com/healthcare/merck-ends-covid-19-vaccine-program-cites-inferior-immune-responses.
News.